| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 |
| filingDate |
1990-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b221e02774c249fe6bfb11648bc23dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5000e821dcb87528c7b4fc9df071990f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d031fd38f332798ddd277a0ab1a18f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe73afecf88e98c36aa00bb6550b4f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cfe6387bf603ca7e969e73003fd044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca445b7144804fc2da0e6dcd4f62dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43127c77fce3ee8128c3ffc7bce7f60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d04a74177224337ed3afc13315bfac4 |
| publicationDate |
1992-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0485512-A1 |
| titleOfInvention |
Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine antagonists. |
| abstract |
Methods for treating cocaine dependence, the acute effects of cocaine, and the need to absorb cocaine in mammals through the use of a cocaine antagonist having the general formula (I). Treatment methods can counteract cocaine intoxication and may prevent a repeat use of the drug during and after treatment. Preferably, (1- [2- [bis (4-fluorophenyl) -methoxy] ethyl] -4- [3-phenylpropyl] -piperizine is administered from 0.1 mg to 100 mg per kilogram of body weight per day. |
| priorityDate |
1989-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |